Wall Street expects a year-over-year increase in earnings on higher revenues when Labcorp (LH) reports results for the quarter ended September 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on October 24. On ...

Labcorp Holdings Inc. (LH) , or Labcorp, is slated to report its third-quarter 2024 results on Oct. 24, before the market opens. The renowned laboratory service provider reported adjusted earnings of $3.94 in the last reported quarter, topping the Zacks Consensus Estimate by 4.23%. Labcorp surpassed estimates in each of the trailing four quarters, the average surprise being 2.80%. Find the latest EPS estimates and surprises on Zacks Earnings Calendar. LH's Q3 Estimates The Zacks Consensus Estimate for Labco ...

BURLINGTON, N.C., Oct. 10, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on December 13, 2024, to stockholders of record as of the close of business on November 26, 2024. About Labcorp Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, phar ...

Labcorp Holdings, Inc. (LH) or Labcorp benefits from the solid execution of its strategic priorities. Investment in targeted high-growth areas should drive the momentum. The company faces headwinds from macroeconomic uncertainties and growing foreign exchange issues. The stock carries a Zacks Rank #3 (Hold) currently. Factors Driving LH Stock LabCorp is well-placed for long-term success in Cell & Gene Therapy, expanding into the consumer market and international growth through the specialty testing and biop ...

Labcorp Holdings Inc. (LH) is making strides in expanding testing solutions in strategic growth areas. The company is improving its margin performance through the benefits of the LaunchPad initiative, which is nearing its targeted savings goal. Its strategic partnerships with health systems and regional labs are also poised to boost growth in the upcoming quarters. Meanwhile, uncertain macroeconomic conditions and a debt-laden balance sheet raise worry for Labcorp's operations. In the past year, this Zacks ...

BURLINGTON, N.C., Sept. 24, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third quarter of 2024 before the market opens on Thursday, October 24, 2024. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website. The call will be webca ...

Labcorp (LH) has announced the expansion of its molecular bioanalytical laboratory in Greenfield, IN. The expanded facility will increase the company's global molecular bioanalytical capacity, enabling the company to help biopharmaceutical customers bring life-saving advanced therapies to patients faster. The latest development is expected to positively boost the company's Central Laboratories business under the Biopharma Laboratory Services ("BLS") segment. Predicting LH Stock Movement Following the News S ...

The American College of Obstetricians and Gynecologists (ACOG) recommends postpartum care be treated as an ongoing process rather than a single doctor's visit. However, estimates suggest that a significant number of women do not attend even one postpartum appointment, in part due to access barriers like lack of health insurance, transportation and childcare. "The postpartum period is a precarious time for women in the United States. Current standards of care provide insufficient support for women who may be ...

Labcorp Holdings Inc. (LH) recently announced the completion of its acquisition of select assets of BioReference Health — a wholly-owned subsidiary of OPKO Health, Inc. (OPK). The transaction is aimed at providing customers with greater access to Labcorp's comprehensive, high-quality laboratory services, scientific expertise and expanded testing capabilities in key regions across the United States. Likely Trend of LH Stock Following the News Following the announcement, shares of Labcorp rose 2.1% to $225.76 ...

BURLINGTON, N.C., Sept. 16, 2024 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE:LH) (Labcorp) announced today that its wholly owned subsidiary, Laboratory Corporation of America Holdings (LCAH), has priced its offering of $2,000,000,000 in senior notes (the Offering). The Offering consists of three tranches: $650,000,000 aggregate principal amount of 4.350% Senior Notes due 2030 (the 2030 Notes), $500,000,000 aggregate principal amount of 4.550% Senior Notes due 2032 (the 2032 Notes) and $850,000,000 aggregate ...